Log In
Print this Print this

simotinib (SIM6802)

  Manage Alerts
Collapse Summary General Information
Company Simcere Pharmaceutical Group
DescriptionEpidermal growth factor (EGF) receptor tyrosine kinase inhibitor
Molecular Target
Mechanism of ActionEpidermal growth factor (EGF) receptor kinase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationNon-small cell lung cancer (NSCLC)
Indication DetailsTreat non-small cell lung cancer (NSCLC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today